April 7, 2025 · STOCK Act disclosure
Representative Jefferson Shreve (Republican-IN) sold Regeneron Pharmaceuticals, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on April 7, 2025 and was disclosed on May 8, 2025 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.